ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $439,024 | +49.9% | 292,470 | +58.8% | 0.00% | – |
| Q2 2023 | $292,795 | +121.6% | 184,122 | -0.0% | 0.00% | – |
| Q1 2023 | $132,147 | +112846.2% | 184,146 | -8.4% | 0.00% | – |
| Q4 2022 | $117 | -100.0% | 200,974 | -27.2% | 0.00% | – |
| Q3 2022 | $262,000 | -32.3% | 276,109 | -14.6% | 0.00% | – |
| Q2 2022 | $387,000 | -50.3% | 323,146 | -45.6% | 0.00% | – |
| Q1 2022 | $778,000 | -35.7% | 593,619 | -13.6% | 0.00% | – |
| Q4 2021 | $1,210,000 | -25.4% | 687,130 | -8.1% | 0.00% | -100.0% |
| Q3 2021 | $1,622,000 | -63.8% | 747,329 | -41.6% | 0.00% | 0.0% |
| Q2 2021 | $4,479,000 | -67.5% | 1,279,810 | -8.5% | 0.00% | -80.0% |
| Q1 2021 | $13,761,000 | -25.8% | 1,398,438 | -18.2% | 0.01% | -28.6% |
| Q4 2020 | $18,537,000 | -3.9% | 1,709,739 | -8.7% | 0.01% | -12.5% |
| Q3 2020 | $19,280,000 | -50.4% | 1,871,770 | +0.4% | 0.01% | -52.9% |
| Q2 2020 | $38,909,000 | +112.0% | 1,863,474 | -0.8% | 0.02% | +70.0% |
| Q1 2020 | $18,354,000 | -16.6% | 1,878,245 | -1.7% | 0.01% | +25.0% |
| Q4 2019 | $22,014,000 | +87.6% | 1,911,033 | -11.3% | 0.01% | +60.0% |
| Q3 2019 | $11,736,000 | -54.4% | 2,153,382 | -0.6% | 0.01% | -50.0% |
| Q2 2019 | $25,750,000 | +158.4% | 2,165,912 | +13.9% | 0.01% | +150.0% |
| Q1 2019 | $9,967,000 | +78.9% | 1,902,150 | +7.6% | 0.00% | +33.3% |
| Q4 2018 | $5,570,000 | -43.9% | 1,768,246 | +7.7% | 0.00% | -25.0% |
| Q3 2018 | $9,933,000 | +16.7% | 1,641,732 | +2.2% | 0.00% | +33.3% |
| Q2 2018 | $8,514,000 | +24.5% | 1,606,407 | +36.2% | 0.00% | 0.0% |
| Q1 2018 | $6,839,000 | +107.9% | 1,179,192 | +25.5% | 0.00% | +200.0% |
| Q4 2017 | $3,289,000 | +66.9% | 939,611 | +74.0% | 0.00% | 0.0% |
| Q3 2017 | $1,971,000 | +158.7% | 540,097 | +77.2% | 0.00% | – |
| Q2 2017 | $762,000 | +158.3% | 304,741 | +179.3% | 0.00% | – |
| Q1 2017 | $295,000 | +213.8% | 109,121 | +236.5% | 0.00% | – |
| Q4 2016 | $94,000 | +2.2% | 32,429 | +45.3% | 0.00% | – |
| Q3 2016 | $92,000 | +61.4% | 22,325 | +23.5% | 0.00% | – |
| Q2 2016 | $57,000 | – | 18,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |